HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemia.

Abstract
Decitabine (DAC) is used for treatment of patients with myelodysplastic syndromes and acute myeloid leukemia (AML). Following cellular uptake, DAC is activated to DAC-triphosphate (TP) and incorporated into DNA. Once incorporated into the DNA, DAC-TP binds and inactivates DNA methyltransferases (DNMTs), thereby leading to hypomethylation and re-expression of epigenetically silenced tumor suppressor genes and ultimately antileukemia activity. However, direct evidence of in vivo DAC-TP occurrence in DAC-treated patients has been difficult to demonstrate due to a lack of suitable validated analytical methodology. Thus, we developed and validated a nonradioactive sensitive and specific LC-MS/MS assay for quantification of DAC-TP. The assay is linear from 50 to 1,000 nM and from 1 to 10 μM and has a lower limit of quantitation of 50 nM and a coefficient of variation for both within- and between-day precision <20%. Following DAC treatment, we detected DAC-TP in parental and DAC-resistant AML cells (in vitro) and bone marrow (BM) and spleen of normal and leukemic mice (in vivo). Downregulation of DNMTs and correlation of DAC-TP concentration with proteins involved in mechanisms of DAC resistance were also demonstrated. The clinical applicability of this method was proven by measuring DAC-TP level in BM and blood mononuclear cells from DAC-treated AML patients. Higher levels are seemingly associated with clinical response. Monitoring the DAC-TP intracellular level may serve as a novel pharmacological endpoint for designing more effective DAC-based regimens.
AuthorsHongyan Wang, Ping Chen, Jiang Wang, Ramasamy Santhanam, Josephine Aimiuwu, U V Vijaya Saradhi, Zhongfa Liu, Sebastian Schwind, Alice Mims, John C Byrd, Michael R Grever, Miguel A Villalona-Calero, Rebecca Klisovic, Alison Walker, Ramiro Garzon, William Blum, Kenneth K Chan, Guido Marcucci
JournalThe AAPS journal (AAPS J) Vol. 15 Issue 1 Pg. 242-9 (Jan 2013) ISSN: 1550-7416 [Electronic] United States
PMID23180159 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antimetabolites, Antineoplastic
  • Polyphosphates
  • Decitabine
  • DNA Modification Methylases
  • Azacitidine
  • triphosphoric acid
Topics
  • Animals
  • Antimetabolites, Antineoplastic (metabolism)
  • Azacitidine (analogs & derivatives, metabolism)
  • DNA Modification Methylases (antagonists & inhibitors)
  • Decitabine
  • Humans
  • Leukemia, Myeloid, Acute (drug therapy)
  • Mice
  • Mice, Inbred C57BL
  • Polyphosphates (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: